Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating FOLFOXIRI as neoadjuvant chemotherapy for high-risk locally advanced colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver [NA]
A terminated clinical trial evaluating Yttrium-90 radioactive resin microspheres for colorectal cancer liver metastases; results were posted…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of CPGJ602 with chemotherapy as first-line treatment for metastatic colorectal cancer wi…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer [Phase 1, Phase 2]
Phase 1/2 safety study of hMN14 for colorectal cancer and breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Safety Study of 90Y-hMN14 to Treat Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for safety study of 90Y-hMN14 in colorectal cancer (Phase 1/Phase 2) completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT) [Phase 2]
A Phase 2 trial evaluating cetuximab and vemurafenib in combination with FOLFIRI for BRAF V600E mutated advanced colorectal cancer is being …
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Impact of Family History and Decision Support on High-risk Cancer Screening [NA]
A completed clinical trial evaluating the impact of family history and decision support on high-risk colorectal cancer screening.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer [Phase 1]
Phase 1 clinical trial update of a monoclonal antibody therapy for advanced colorectal cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery [Phase 3]
Phase 3 trial evaluating oxaliplatin, leucovorin calcium, and fluorouracil with or without celecoxib for stage III colorectal cancer post-su…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening [Phase 1]
Phase 1 clinical trial evaluating a health service intervention to improve access and adherence to colorectal cancer screening.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating toripalimab plus bevacizumab and chemotherapy as neoadjuvant therapy in advanced MSI-H or dMMR colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer [Phase 3]
Phase 3 trial investigating aprepitant without steroid for preventing chemotherapy-induced nausea and vomiting in colorectal cancer patients…
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC [Phase 2]
This update reports the completion of a Phase 2 study evaluating TAS-102 plus nivolumab in patients with metastatic colorectal cancer; resul…
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating irinotecan bead chemoembolisation before surgery in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: TAS-OX for Refractory Metastatic Colon Cancer [Phase 1, Phase 2]
Clinical trial update for TAS-OX in refractory metastatic colon cancer (colorectal neoplasms) across Phase 1 and Phase 2; results posted aft…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical study evaluating pyrotinib in patients with HER2-positive advanced colorectal cancer; status not specified.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab [Phase 2]
Phase 2 clinical trial evaluating biomarkers in colorectal cancer patients with native KRAS treated with chemotherapy plus cetuximab; study …
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal [Phase 2]
Phase 2 trial update evaluating second-line FOLFIRI plus panitumumab in patients with wild-type RAS metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer [Phase 3]
Phase III trial of Xilonix in advanced/metastatic colorectal cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial studying LGX818 (dabrafenib) and cetuximab, or LGX818, BYL719 (alpelisib), and cetuximab in BRAF-mutant metastatic colorectal …
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Health Literacy Interventions to Overcome Disparities in CRC Screening [NA]
Completed clinical trial on health literacy interventions to overcome disparities in colorectal cancer screening; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status [Phase 2]
A Phase 2 trial evaluating first-line FOLFIRI plus panitumumab in elderly patients with unresectable metastatic colorectal cancer that is RA…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating MEDI4736 (durvalumab) in immunological subsets of advanced colorectal cancer has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating surufatinib in combination with immunotherapy and chemotherapy for second-line treatment of advanced colorectal…